AACR Stories
A grant from the AACR helped Yale University cancer scientist Luisa Escobar-Hoyos, MSc, PhD, earn two major, multi-year federal grants to advance her research to better treat pancreatic and lung cancers.
Learn More
A grant from the AACR helped Yale University cancer scientist Luisa Escobar-Hoyos, MSc, PhD, earn two major, multi-year federal grants to advance her research to better treat pancreatic and lung cancers.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn More
In this episode of Believe in Progress, Mitch talks with Joe Krajewski—a devoted father, runner, and cancer advocate—about turning the tragedy of losing his son, Will, to osteosarcoma into a personal mission to defeat cancer.
Listen and Subscribe
Ewing sarcoma is a rare type of cancer with an incidence that is nine times greater in Caucasians than in African Americans. July is Sarcoma Awareness Month.
Learn More
Research-driven advances in our understanding of the immune system invigorated the field of cancer immunology and established immunotherapy as the fifth pillar of cancer medicine.
Read the Report
Read about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn More
Whether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate Now
The official news website of the AACR Annual Meeting 2025. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now